Recruiting NA Alzheimer's Disease (AD)

New treatment option for Alzheimer's Disease (AD)

Official title Social-cognitive Functioning: Validation of a New Neuropsychological Test

ClinicalTrials.gov ID: NCT05558709

What this study is testing

What it's testing
It is now established that disturbances in social cognition are frequent in neurology and that they contribute to the development of social conduct disorders. Their assessment is therefore essential, particularly in order to propose early and adapted care.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 90. Healthy volunteers may be eligible.

You may be able to join if

  • For patients:
  • Patient aged between 18 and 90 years
  • Mini Mental State Examination (MMSE) score greater than or equal to 20
  • Patient able to express his or her non-opposition to participate in the study in an informed and autonomous manner
  • Patient with a neurodegenerative pathology: FTD, AD or LBD. For caregivers:

You likely can't join if

  • For patients:
  • Neurological or psychiatric comorbidity
  • Notable sensory disorders (e.g., profound or total deafness, age-related macular degeneration, blindness, etc.) that may interfere with experimental...
  • Opposition to participation in the study
See the full eligibility criteria
Who can join
  • For patients:
  • Patient aged between 18 and 90 years
  • Mini Mental State Examination (MMSE) score greater than or equal to 20
  • Patient able to express his or her non-opposition to participate in the study in an informed and autonomous manner
  • Patient with a neurodegenerative pathology: FTD, AD or LBD. For caregivers:
  • Over 18 years of age
  • Regular contact with the patient (≥ 2 times per month)
What rules you out
  • For patients:
  • Neurological or psychiatric comorbidity
  • Notable sensory disorders (e.g., profound or total deafness, age-related macular degeneration, blindness, etc.) that may interfere with experimental completion.
  • Opposition to participation in the study

The study team makes the final eligibility decision.

Where it's taking place

  • Paris, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.